SCHEMBL17646293

SCHEMBL17646293

CC(C)(C)N(C(=O)O)[C@H](CCCCNC(=O)OCc1ccccc1)C(=O)c1nc2ccccc2s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 4/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
MAPT P10636 1/20 0.45
DPP8 Q6V1X1 1/20 0.42
DPP7 Q9UHL4 1/20 0.42
BRD4 O60885 1/20 0.42
TPSAB1 Q15661 2/20 0.42
TPSD1 Q9BZJ3 2/20 0.42
TPSG1 Q9NRR2 2/20 0.42
MMP2 P08253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17646308 1.00 FOLH1 (0.47) FOLH1HDAC3HDAC4HDAC1HDAC7
SCHEMBL17661731 0.84 HDAC3 (0.51) FOLH1HDAC3HDAC4HDAC1HDAC7
SCHEMBL17646322 0.83 FOLH1 (0.49) FOLH1HDAC6MAPTDPP8DPP7
SCHEMBL17646310 0.82 MAPT (0.58) FOLH1HDAC3HDAC4HDAC1HDAC7
SCHEMBL19665637 0.82 MAPT (0.58) FOLH1HDAC3HDAC4HDAC1HDAC7
SCHEMBL17646294 0.82 MAPT (0.58) FOLH1HDAC3HDAC4HDAC1HDAC7
SCHEMBL17672361 0.82 ANPEP (0.55) FOLH1HDAC3HDAC4HDAC1HDAC7
SCHEMBL17646246 0.82 ANPEP (0.55) FOLH1HDAC3HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL17646327 0.81 ANPEP (0.54) FOLH1HDAC3HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL21489552 0.81 ANPEP (0.54) FOLH1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332464-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2022-05-17 US disclosed
US-20210017167-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2021-01-21 US disclosed
EP-3204352-B1 INHIBITORS OF LYSINE GINGIPAIN CORTEXYME INC (US) 2020-07-01 EP disclosed
US-10676470-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2020-06-09 US disclosed
US-20190322659-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2019-10-24 US disclosed
US-10301301-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2019-05-28 US disclosed
US-20180346460-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2018-12-06 US disclosed
US-9988375-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2018-06-05 US disclosed
US-20170349537-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2017-12-07 US disclosed
US-9758473-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2017-09-12 US disclosed
US-20160096830-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180346460-A1 INHIBITORS OF LYSINE GINGIPAIN ENPEP, PHYKPL, PREP FOLH1 216/4885HDAC3 1067/4885HDAC4 790/4885
US-20190322659-A1 INHIBITORS OF LYSINE GINGIPAIN ENPEP, PHYKPL, PREP FOLH1 216/4885HDAC3 1067/4885HDAC4 790/4885
US-20210017167-A1 INHIBITORS OF LYSINE GINGIPAIN ENPEP, PHYKPL, PREP FOLH1 216/4885HDAC3 1067/4885HDAC4 790/4885
US-10676470-B2 Inhibitors of lysine gingipain ENPEP, PHYKPL, PREP FOLH1 216/4885HDAC3 1067/4885HDAC4 790/4885
US-20170349537-A1 INHIBITORS OF LYSINE GINGIPAIN ENPEP, PHYKPL, PREP FOLH1 216/4885HDAC3 1067/4885HDAC4 790/4885
US-20160096830-A1 INHIBITORS OF LYSINE GINGIPAIN ENPEP, PHYKPL, PREP FOLH1 216/4885HDAC3 1067/4885HDAC4 790/4885
US-11332464-B2 Inhibitors of lysine gingipain ENPEP, PHYKPL, PREP FOLH1 216/4885HDAC3 1067/4885HDAC4 790/4885
US-10301301-B2 Inhibitors of lysine gingipain ENPEP, PHYKPL, PREP FOLH1 216/4885HDAC3 1067/4885HDAC4 790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.